HIVE vs BTBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 25, 2026

HIVE

54.0
AI Score
VS
HIVE Wins

BTBT

52.9
AI Score

Investment Advisor Scores

HIVE

54score
Recommendation
HOLD

BTBT

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIVE BTBT Winner
Revenue 225.97M 27.92M HIVE
Net Income -72.11M -146.67M HIVE
Net Margin -31.9% -525.2% HIVE
ROE -12.9% -31.3% HIVE
ROA -11.6% -12.4% HIVE
Total Assets 624.00M 1.18B BTBT
Cash 14.07M 79.53M BTBT
Current Ratio 1.74 6.36 BTBT

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.